News from NORD

NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans


 

NORD has joined several other patient organizations in voicing opposition to proposed expansion of short-term, limited-duration health plans. NORD and its advocacy partners believe that expanding these plans would destabilize the insurance marketplace and increase premiums for those who are in the greatest need of care. For information, view the coalition letter to Congress here and letter to the Administration here.

Recommended Reading

Maintenance chemo boosts survival for youth with high-risk rhabdomyosarcoma
MDedge Pediatrics
FDA approves Epidiolex for Lennox-Gastaut syndrome and Dravet syndrome
MDedge Pediatrics
Limited anakinra course often enough for systemic JIA if used first
MDedge Pediatrics
Study supports meningococcal B vaccine in children with rare diseases
MDedge Pediatrics
Study offers snapshot of esophageal strictures in EB patients
MDedge Pediatrics
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Pediatrics
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Pediatrics
RFPs Available for the Study of Three Rare Diseases
MDedge Pediatrics
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Pediatrics
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Pediatrics